Avoro Capital Advisors LLC

13F Portfolio Filings

Latest 13F report
Q2 2024 - Aug 14, 2024
Value $
$7.51B
Signature - Title
Scott Epstein - Chief Compliance Officer & COO
Location
110 Greene Street, Suite 800, New York, NY
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q2 2024 41 $7.51B +$255M -$1.18B -$924M UTHR, MDGL, ASND, ARGX, SRPT 13F-HR 8/14/2024, 07:58 AM
Q1 2024 46 $8.57B +$1.7B -$873M +$830M UTHR, APLS, ASND, SRPT, MDGL 13F-HR 5/15/2024, 08:07 AM
Q4 2023 42 $7.24B +$1.52B -$1.48B +$39M APLS, UTHR, ASND, ARGX, MDGL 13F-HR 2/14/2024, 12:05 PM
Q3 2023 50 $6.4B +$267M -$764M -$497M HZNP, UTHR, ARGX, SRPT, APLS 13F-HR 11/14/2023, 06:32 AM
Q2 2023 45 $7.37B +$486M -$166M +$320M APLS, HZNP, UTHR, SRPT, ARGX 13F-HR 8/14/2023, 08:33 AM
Q1 2023 39 $6.74B +$304M -$21.4M +$283M HZNP, APLS, UTHR, SRPT, ARGX 13F-HR 5/15/2023, 09:09 AM
Q4 2022 36 $6.69B +$473M -$35.8M +$437M UTHR, HZNP, APLS, MDGL, ARGX 13F-HR 2/14/2023, 08:04 AM
Q3 2022 39 $5.41B +$264M -$126M +$139M APLS, UTHR, ARGX, MRTX, SRPT 13F-HR 11/14/2022, 08:28 AM
Q2 2022 39 $5.05B +$322M -$297M +$24.6M UTHR, ARGX, APLS, HZNP, MRTX 13F-HR 8/15/2022, 08:54 AM
Q1 2022 43 $5.48B +$789M -$296M +$492M HZNP, UTHR, APLS, MRTX, ARGX 13F-HR 5/16/2022, 08:57 AM
Q4 2021 39 $5.86B +$640M -$253M +$388M HZNP, MRTX, UTHR, APLS, ARGX 13F-HR 2/14/2022, 08:03 AM
Q3 2021 43 $6.36B +$625M -$364M +$262M HZNP, MRTX, XLRN, UTHR, ASND 13F-HR 11/15/2021, 09:04 AM
Q2 2021 44 $5.74B +$644M -$498M +$147M HZNP, MRTX, UTHR, XLRN, ARGX 13F-HR 8/16/2021, 09:05 AM
Q1 2021 46 $5.79B +$1.09B -$373M +$721M HZNP, MRTX, UTHR, XLRN, VRTX 13F-HR 5/17/2021, 09:29 AM
Q4 2020 44 $5.81B +$1.14B -$304M +$834M MRTX, HZNP, UTHR, IOVA, ARNA 13F-HR 2/16/2021, 11:33 AM
Q3 2020 45 $7.04B +$727M -$221M +$506M IMMU, MRTX, HZNP, IOVA, ASND 13F-HR 11/16/2020, 08:02 AM
Q2 2020 44 $5.06B +$743M -$137M +$606M IMMU, MRTX, HZNP, IOVA, SRPT 13F-HR 8/14/2020, 10:00 AM
Q1 2020 41 $2.96B +$489M -$50.7M +$439M IMMU, MRTX, IOVA, ASND, BMRN 13F-HR 5/15/2020, 01:03 PM
Q4 2019 30 $3.4B +$495M -$309M +$185M IMMU, MRTX, ASND, IOVA, SRPT 13F-HR 2/14/2020, 08:47 AM
Q3 2019 33 $2.4B +$220M -$62.6M +$158M MRTX, IMMU, IOVA, ASND, BMRN 13F-HR 11/14/2019, 11:40 AM
Q2 2019 34 $2.89B +$531M -$40.8M +$490M MRTX, IMMU, IOVA, ASND, SRPT 13F-HR 8/14/2019, 12:04 PM
Q1 2019 32 $2.31B +$301M -$155M +$146M IMMU, MRTX, ASND, AMRN, SRPT 13F-HR 5/15/2019, 12:26 PM
Q4 2018 35 $1.67B +$200M -$48.1M +$152M IMMU, MRTX, SRPT, ASND, BMRN 13F-HR 2/14/2019, 10:11 AM
Q3 2018 45 $2.18B +$170M -$280M -$111M IMMU, MRTX, SRPT, ASND, BMRN 13F-HR 11/14/2018, 10:16 AM
Q2 2018 41 $2.59B +$692M -$123M +$568M IMMU, MRTX, BMRN, FOLD, ASND 13F-HR 8/14/2018, 11:25 AM
Q1 2018 52 $2.09B +$563M -$78.5M +$484M IMMU, FOLD, BMRN, IOVA, MRTX 13F-HR 5/15/2018, 12:51 PM
Q4 2017 44 $1.53B +$360M -$46.2M +$314M IMMU, BMRN, FOLD, MRTX, CLVSQ 13F-HR 2/14/2018, 10:43 AM
Q3 2017 40 $1.27B +$446M -$93.2M +$353M IMMU, FOLD, KITE, ARRY, CLVSQ 13F-HR 11/14/2017, 11:23 AM
Q2 2017 43 $791M +$189M -$102M +$87.5M IMMU, KITE, FOLD, TSRO, BMRN 13F-HR 8/14/2017, 12:30 PM
Q1 2017 42 $782M +$310M -$36.3M +$273M IMMU, TSRO, MDCO, ACAD, BMRN 13F-HR 5/15/2017, 12:20 PM
Q4 2016 39 $494M +$101M -$36.3M +$64.3M ACAD, IMMU, BMRN, LBIO, TSRO 13F-HR 2/14/2017, 11:27 AM
Q3 2016 44 $563M +$109M -$39.1M +$70M SRPT, BMRN, LBIO, TSRO, FOLD 13F-HR 11/14/2016, 02:38 PM
Q2 2016 39 $445M +$184M -$20.2M +$164M TSRO, LBIO, CPXX, BMRN, BMY 13F-HR 8/15/2016, 04:09 PM
Q1 2016 36 $285M +$129M -$35.6M +$93.8M MRTX, FOLD, BMRN, SRPT, GILD 13F-HR 5/16/2016, 04:06 PM
Q4 2015 28 $290M +$23.4M -$51.8M -$28.5M MRTX, FOLD, LBIO, LJPC, SRPT 13F-HR 2/12/2016, 11:00 AM
Q3 2015 32 $383M +$129M -$7.18M +$122M FOLD, MRTX, VNDA, LJPC, ACAD 13F-HR 11/13/2015, 11:27 AM
Q2 2015 31 $363M +$142M -$10.6M +$132M FOLD, SRNEQ, MRTX, LBIO, ONTY 13F-HR 8/14/2015, 12:31 PM
Q1 2015 33 $243M +$120M -$20.8M +$99.7M FOLD, LBIO, SRNEQ, PTX, BLCM 13F-HR 5/15/2015, 11:59 AM
Q4 2014 29 $142M FOLD, TARO, RCPT, PTX, AGEN 13F-HR 2/13/2015, 12:07 PM